ImmunoGen Inc., of Waltham, Mass., appointed James J. O'Leary vice president and chief medical officer...Infinity Pharmaceuticals Inc., of Cambridge, Mass., promoted Adelene Q. Perkins president and chief business officer...It also appointed Bruce R. Thaw chairman and named James E. Rothman chairman of the scientific advisory board

The company appointed Craig A. Collard president and CEO and named Alastair McEwan chairman...It also appointed Christopher Codeanne, Michael Enright and Michael Heffernan to the board

Bioheart Inc., of Sunrise, Fla., appointed Matt Fendrich vice president of sales and marketing and named Alan P. Timmins to the board...Biovail Corp., of Toronto, appointed H. Christian Fibiger senior vice president and chief scientific officer of Biovail Laboratories International SRL...BioXcel Corp., of New Haven, Conn., added R. Christopher Seaton, Martha Matteo and Kevin Rakin to its corporate advisory board

AAIPharma, of Wilmington, N.C., appointed Andreas Dreps senior vice president of global clinical development services and named Ralf Wolter vice president of clinical operations, Europe...Adimab Inc., of Lebanon, N.H., appointed Guy Van Meter senior director and head of business development...Antisoma plc, of London, appointed Eric Dodd chief financial officer and board member

UCB SA, of Brussels, Belgium, appointed Michele Antonelli executive vice president of technical operations and quality assurance and named Mark McDade executive vice president of global operations

Quinnova Pharmaceuticals Inc., of Newtown, Pa., appointed Christopher Hensby senior vice president of research and development...Seattle Genetics Inc., of Bothell, Wash., named Elaine Waller senior vice president of regulatory affairs and appointed Christopher Pawlowicz senior vice president of human resources...Somnus Therapeutics Inc., of Bedminster, N.J., appointed Gary Cupit, Linda C. Hogan, David Ramsay and Jack W. Britts to its board

It also named Chas Bountra as chairman and Annette Dolphin to its scientific advisory board...and Faith Pomeroy-Ward as executive director of investor relations and corporate communications

Abeome Corp., of Athens, Ga., formed a scientific advisory board, led by Richard Meagher, with the appointments of Christine Debouck, Jeff Boyd and Linda Matsuuchi...It formed its scientific advisory board with the appointments of Dennis Brown, Xandra Breakefield and Richard L. Edelson, and also appointed Johan Skog director of genetics research

Prometheus Laboratories Inc., of San Diego, named Mark Spring senior vice president and chief financial officer...Targanta Therapeutics Corp., of Cambridge, Mass., appointed Stéphane Bancel and Rosemary A. Crane to its board...Trubion Pharmaceuticals Inc., of Seattle, appointed Scott C. Stromatt senior vice president and chief medical officer

Arcxis Biotechnologies, of Pleasanton, Calif., named Christine Meda president and CEO...Calibrant Biosystems, of Gaithersburg, Md., appointed James Hawkins, Bethany Mancilla and Douglas Swirsky to its business advisory board...Lipoxen plc, of London, promoted Peter Laing to chief operating officer and appointed Ajay K. Agrawal head of business development

Tengion Inc., of East Norriton, Pa., named Mark Stejbach vice president of marketing and commercial planning...TheraGenetics Ltd., of Cambridge, Mass., and London, appointed Susan E. Bromley global head of R&D and named Kenneth B. Milne UK director of R&D

PolyMedix Inc., of Radnor, Pa., elected Richard Bank and Stefan Loren to its board...PPD Inc., of Wilmington, N.C., appointed Christine Dingivan executive vice president and chief medical officer

GenVault Corp., of Carlsbad, Calif., named Myla P. Lai-Goldman and Jack Ballantyne to its scientific advisory board...Illumina Inc., of San Diego, appointed Mostafa Ronaghi senior vice president and chief technology officer...MediGene AG, of Martinsried, Germany, said Thomas Strüngmann and Mathias Albert Boehringer were elected as new supervisory board members

Alverix Inc., of San Jose, Calif., named James D. Merselis president and CEO, and a member of the board of directors...Amsterdam Molecular Therapeutics, of Amsterdam, the Netherlands, appointed Janneke de Wal director global marketing and sales

David Mitchell senior director of regulatory affairs and quality assurance...and Jay Rheingold vice president of chemistry, manufacturing and controls

Exiqon, of Vedbaek, Denmark, appointed Cynthia K. French chief scientific officer and Erik Holmlin chief commercial officer...Ikonysis, of New Haven, Conn., named Louise Mawhinney senior vice president and chief financial officer...PharmAthene Inc., of Annapolis, Md., appointed Jordan P. Karp senior vice president and general counsel

Javelin Pharmaceuticals Inc., of Cambridge, Mass., named Daniel Carr president and said Fred Mermelstein assumed the role of executive director...Oncothyreon Inc., of Bellevue, Wash., named Daniel K. Spiegelman and Stephen K. Burley to its board...Pantec Biosolutions AG, of Ruggell, Leichtenstein, appointed Burkhard Feurstein and Michael Armbruester to its board

Adolor Corp., of Exton, Pa., promoted Lee Techner to vice president of medical affairs and medical director...It also named Guido Magni to its board and the governance and nominating committee

VirtualHealth Technologies Inc., of Lexington, Ky., named Robert Tapales vice president of operations. Westfield Capital Management, of Boston, named Lawrence C. Fritz Life Sciences Venture Partner. WuXi PharmaTech, of Shanghai, China, appointed Peng Wang vice president of discovery biology. XTL Biopharmaceuticals Ltd., of Valley College, N.Y., appointed Laurence N. Charney to its board.